Detection of rare mutant alleles by restriction endonuclease-mediated selective-PCR: Design and optimization

Clinical Chemistry

Volumn 46, Issue 5, 2000, Pages 620-624

  Fuery, Caroline J ^a   Impey, Helen L ^a   Roberts, Natalie J ^a   Applegate, Tanya L ^a   Ward, Robyn L ^b   Hawkins, Nicholas J ^c   Sheehan, Catherine A ^b   O'Grady, Roslyn ^b   Tood, Alison V ^a  

^a JOHNSON AND JOHNSON   (United States)

^b ST VINCENT S HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; PLASMID DNA; RESTRICTION ENDONUCLEASE;

ALLELE; ARTICLE; CANCER CELL; CELL STRAIN K 562; CODON; GENE MUTATION; HUMAN; HUMAN CELL; ONCOGENE K RAS; POINT MUTATION; POLYMERASE CHAIN REACTION;

EID: 0034113440     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.5.620     Document Type: Article

References (12)

1. 1. Perucho M. PCR and cancer diagnostics: detection and characterization of single point mutations in oncogenes and antioncogenes. In: Mullis KB, Ferre T, Gibbs RA, eds. The polymerase chain reaction. Boston: Birkhauser, 1994:269-394.
2. 2. Todd A, Iland HJ. Rapid screening of mutant N-ras alleles by analysis of PCR-induced restriction sites: allele specific restriction analysis (ASRA). Leuk Lymphoma 1991;3:293-330.
3. 3. Todd A, Ireland CM, Radloff TJ, Kroenberg H, Iland HJ. Analysis of N-ras gene mutations in acute myeloid leukemia by allele specific restriction analysis. Am J Hematol 1991;38;207-13.
4. 4. Cohen JB, Levinson AD. A point mutation in the last intron responsible for increased expression and transforming activity of the c-Ha-ras oncogene. Nature 1988;334:119-24.
5. 5. Todd A. Allele-specific enrichment: a method for the detection of low level N-ras gene mutations in acute myeloid leukemia. Leukemia 1991;5:160-1.
6. 6. Levi S, Urbano-Ispizua A, Gill R, Thomas DM, Gilbertson J, Foster C, Marshall CJ. Multiple K-ras codon 12 mutations in cholangio-carcinomas with a sensitive polymerase chain reaction technique. Cancer Res 1991;51:3497-502.
7. 7. Ward R, Hawkins N, O'Grady R, Sheehan C, O'Connor T, Impey H, et al. Restriction endonuclease-mediated selective polymerase chain reaction: a novel assay for the detection of K-ras mutations in clinical samples. Am J Pathol 1998;53:373-9.
8. 8. Roberts NJ, Impey HI, Applegate TL, Fuery CJ, Ward RL, Todd AV. Rapid, sensitive detection of mutant alleles in codon 12 of K-ras by REMS-PCR. Biotechniques 1999;27:418-20.
9. 9. Kwok S, Kellogg DE, McKinney N, Spasic D, Goda L, Levenson C, Sninsky JJ. Effects of primer-template mismatches on the polymerase chain reaction: human immunodeficiency virus type 1 model studies. Nucleic Acids Res 1990;18:999-1005.
10. 10. Sidransky D, Tokino Y, Hamilton SR, Kinzler KW, Levin B, Frost P, Vogelstein B. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992;256: 102-5.
11. 11. Mao L, Hruban RH, Boyle JO, Tockman M, Sidransky D. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 1994;54:1634-7.
12. 12. Duffy MJ. Can molecular markers now be used for early diagnosis of malignancy? Clin Chem 1995;41:1410-3.